Y-mAbs Therapeutics, Inc. (YMAB)

Sep 15, 2025 - YMAB was delisted (reason: acquired by SERB Pharmaceuticals)

8.61

+0.02 (0.23%)

Inactive · Last trade price on Sep 15, 2025

Y-mAbs Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	85.39	87.69	84.82	65.27	34.9	20.75
Revenue Growth	-1.34%	3.38%	29.96%	87.03%	68.18%	-
Gross Profit	69.58	72.43	73.4	57.7	32.38	18.55
Operating Income	-18.11	-25.11	-21.19	-83.32	-115.43	-119.94
Net Income	-22.22	-29.67	-21.43	-95.57	-55.28	-119.34
Earnings Per Share	-0.49	-0.67	-0.49	-2.19	-1.28	-2.97
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	65.98	67.81	46.26	34.9	20.75
Eastern Asia	7.46	-	-	-	-
Latin America	4.72	-	-	-	-
Western Asia	4.05	-	-	-	-
Western Europe	2.09	-	-	-	-
Other Regions	0.89	16.51	3.01	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	62.29	67.23	78.64	105.76	181.56	114.63
Total Debt	3.12	0.82	1.42	1.77	3.63	3.98
Net Cash (Debt)	59.17	66.41	77.22	104	177.93	110.66
Net Cash Growth	-22.69%	-13.99%	-25.75%	-41.55%	60.80%	-46.00%
Net Cash Per Share	1.32	1.50	1.77	2.38	4.12	2.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-17.8	-15.71	-27.23	-75.92	-102.56	-91.23
Capital Expenditures	-0.13	-	-	-	-0.67	-0.18
Free Cash Flow	-17.92	-15.71	-27.23	-75.92	-103.22	-91.41
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	81.49%	82.61%	86.54%	88.41%	92.80%	89.38%
Operating Margin	-21.21%	-28.64%	-24.98%	-127.66%	-330.78%	-578.00%
Pretax Margin	-26.49%	-34.00%	-24.60%	-146.43%	-158.39%	-575.12%
Profit Margin	-26.03%	-33.83%	-25.26%	-146.43%	-158.40%	-575.12%
FCF Margin	-20.99%	-17.92%	-32.11%	-116.32%	-295.79%	-440.51%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '26 Jul 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	4.54	4.00	3.51	3.27	20.27	96.67